PCSK9 inhibitor, ezetimibe, and bempedoic acid: Evidence-based therapies for statin-intolerant patients
Satya Preetham Gunta, James H. O’Keefe, Evan L. O’Keefe, Carl J. Lavie
Topics & Concepts
EzetimibeMedicineStatinMaceInternal medicineAdverse effectFamilial hypercholesterolemiaDyslipidemiaPCSK9Proprotein convertaseEvolocumabCholesterolEndocrinologyPharmacologyGastroenterologyLDL receptorLipoproteinDiseaseConventional PCIApolipoprotein A1Myocardial infarctionLipoproteins and Cardiovascular HealthPharmaceutical Economics and Policy